Absci Corp. (ABSI)
8.45
-0.68
(-7.50%)
USD |
NASDAQ |
Nov 13, 16:00
8.47
+0.02
(+0.24%)
After-Hours: 19:59
Absci Price : 8.45 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 9.37 | 9.40 | 8.32 | 8.45 | 5.486M |
| Nov 12, 2026 | 9.39 | 9.94 | 8.96 | 9.135 | 4.918M |
| Nov 11, 2026 | 10.48 | 10.50 | 9.715 | 10.12 | 5.381M |
| Nov 10, 2026 | 10.37 | 10.92 | 9.675 | 9.97 | 4.103M |
| Nov 09, 2026 | 10.10 | 11.22 | 9.92 | 10.80 | 3.757M |
| Nov 06, 2026 | 9.83 | 10.26 | 9.51 | 10.17 | 4.161M |
| Nov 05, 2026 | 10.03 | 10.13 | 9.00 | 9.39 | 5.118M |
| Nov 04, 2026 | 10.26 | 10.68 | 9.78 | 10.48 | 4.158M |
| Nov 03, 2026 | 10.02 | 10.66 | 9.85 | 10.00 | 2.719M |
| Nov 02, 2026 | 11.29 | 11.32 | 9.68 | 9.69 | 3.813M |
| Oct 30, 2026 | 11.41 | 11.80 | 10.45 | 11.13 | 4.566M |
| Oct 29, 2026 | 11.97 | 12.54 | 11.91 | 12.10 | 4.337M |
| Oct 28, 2026 | 10.55 | 11.89 | 10.43 | 11.88 | 5.835M |
| Oct 27, 2026 | 9.54 | 10.95 | 9.36 | 10.57 | 5.837M |
| Oct 26, 2026 | 9.20 | 9.76 | 9.03 | 9.45 | 3.374M |
| Oct 23, 2026 | 9.28 | 9.35 | 8.965 | 9.18 | 1.890M |
| Oct 22, 2026 | 9.69 | 9.95 | 8.93 | 9.37 | 3.707M |
| Oct 21, 2026 | 9.24 | 10.20 | 9.114 | 10.04 | 5.355M |
| Oct 20, 2026 | 8.465 | 9.10 | 8.22 | 9.07 | 2.826M |
| Oct 19, 2026 | 8.69 | 8.96 | 8.395 | 8.54 | 2.763M |
| Oct 16, 2026 | 8.93 | 8.95 | 8.12 | 8.25 | 3.551M |
| Oct 15, 2026 | 8.43 | 8.945 | 8.23 | 8.88 | 3.396M |
| Oct 14, 2026 | 8.88 | 9.12 | 8.62 | 8.74 | 3.558M |
| Oct 13, 2026 | 9.445 | 9.66 | 9.00 | 9.10 | 3.047M |
| Oct 12, 2026 | 10.06 | 10.09 | 9.43 | 9.67 | 2.862M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Twist Bioscience Corp. | 111.60 |
| Moderna, Inc. | 223.37 |
| Tenax Therapeutics, Inc. | 1.62 |
| Exicure, Inc. | 1.08 |
| Recursion Pharmaceuticals, Inc. | 3.185 |
Price Related Metrics
| PS Ratio | 899.05 |
| Price to Book Value | 6.661 |
| Earnings Yield | -9.40% |
| Market Cap | 1.450B |